Guardion Health Sciences Inc (GHSI)

[Affirmative]

GHSI is Oscillating nicely, the lows will be bought and the high will be sold for a bit but the float is being gathered up again.

[trades2win]

Let’s break this walls down

[Affirmative]

GHSI is fine at .49

[Affirmative]

GHSI will vibrate, then oscillate..... Then Boom!

[Affirmative]

GHSI rock bottom lows! Deal of the century

[Affirmative]

GHSI on watch

[Affirmative]

nice little bump of the lows of .38

[trades2win]

Need a nice reversal tomorrow morning to the upside

[ClayTrader]

* * $GHSI Video Chart 12-31-2020 * *

Link to Video - click here to watch the technical chart video

[Viewmont]

I'm loading!

[Viewmont]

https://schrts.co/msMHBNWH We might see a big upside in a week or so with the new CEO! IMO.

[Viewmont]

Effective as of January 6, 2021 (the “Effective Date”), the Board of Directors (the “Board”) of Guardion Health Sciences, Inc. (the “Company”) has appointed Bret Scholtes as President and Chief Executive Officer and as a director of the Company.

[Viewmont]

There starts the after hour action!

Happy New Year all!

[Pstats]

Getting a shit kid of alerts on this one about new CEO anyone has any information ?

[trades2win]

Buying zone !!!!

[Affirmative]

GHSI right back in the Load Zone! :)

[Affirmative]

GRabbed some mid 40's there :)

[Affirmative]

If we're lucky we could at least a .10 up move from .50 today.

[Affirmative]

And here we go! Off to the races

[Affirmative]

Let's get this pre-market move going.

[trades2win]

Consolidation before the next move up

[Affirmative]

Every penny this gains adds a whole lots a dollar $igns :)

[Affirmative]

Lots of shares gathered up in the low, low 50's :)

[Affirmative]

Lots of shares gathered up in the low, low 50's :)

[Affirmative]

She's right in the loading zone... playing nice tonight lol

[Affirmative]

I traded it a few times last night... it was volatile on Tuesday so I thought no sense letting that volatility go to waste wed night. lol

[Affirmative]

over 100% on GHSI buy on Monday, it's a nice play.

[CyrusDaVirus]

Always does this shit in AH

[slow_feet]

Good volume, looks like possible 2nd attempt to break .60

[saigai]

some guy on the yahoo board says just go straight in and the hell with the ddd..so i trusted him...woo hooo

[wesley_]

.54 nice

[slow_feet]

All eyes are on BNGO/BNGOW, but GHSI looks like it's got some steam...

[GREGG THE GREEK]

.53s


GHSI

[slow_feet]

'bout to bust .50 ...

[CyrusDaVirus]

What a piece of shit. Always flops overnight

[Pstats]

1$$$ call shot here !!

[CyrusDaVirus]

Always sells off AH

[GREGG THE GREEK]

GHSI .49

[GREGG THE GREEK]

Moving again in AH.

Continuation I should say.

GHSI

[Viewmont]

GHSI! MOVED NICELY AFTER HOURS! SURELY A GOOD POP/GAP PRE MARKET TOMORROW IT LOOKS LIKE!

Last Thursday it went up to .628 pre-market! We might see that tomorrow PM!

https://finance.yahoo.com/news/guardion-health-sciences-appoints-seasoned-212000167.html

NEW CEO WILL TAKE GHSI TO HIGH / HIGHER LEVELS! https://www.otcmarkets.com/stock/GHSI/news/story?e&id=1774117

NEW CEO! THIS IS HUGE! Prior to joining Guardion, Mr. Scholtes had been CEO of Omega Protein Corporation, the company said. Before that, he served as Vice President, Origination at GE Energy Financial Services and also worked at Price Waterhouse and Arthur Andersen & Co., Guardion said.

[Viewmont]

https://twitter.com/search?q=GHSI&src=typed_query

https://finance.yahoo.com/news/guardion-health-sciences-appoints-seasoned-212000167.html

Guardion Health Sciences Announces Development of New Vision/Energy Support Drink – EPIQ-V

https://finance.yahoo.com/news/guardion-health-sciences-announces-development-130000431.html

[Viewmont]

MOVING NICELY AFTER HOURS! SURELY A GOOD POP IN THE PRE MARKET TOMORROW! IMO.

[Viewmont]

NEW CEO WILL TAKE GHSI TO HIGH / HIGHER LEVELS! https://www.otcmarkets.com/stock/GHSI/news/story?e&id=1774117

[Viewmont]

Last Thursday it went up to .628 pre-market! We might see that tomorrow PM!

IMO.

[Viewmont]

POP / GAP IN THE PM IT LOOKS LIKE!

[Viewmont]

THIS IS HUGE! Prior to joining Guardion, Mr. Scholtes had been CEO of Omega Protein Corporation, the company said. Before that, he served as Vice President, Origination at GE Energy Financial Services and also worked at Price Waterhouse and Arthur Andersen & Co., Guardion said.

[Viewmont]

GRABBING SHARES ALL I CAN NOW!

[Viewmont]

Guardion Health Sciences Inc. on Monday said Bret Scholtes would join the company as president and chief executive officer as of Jan. 6, 2021.

The company also said Mr. Scholtes would become a member of the board.

Prior to joining Guardion, Mr. Scholtes had been CEO of Omega Protein Corporation, the company said. Before that, he served as Vice President, Origination at GE Energy Financial Services and also worked at Price Waterhouse and Arthur Andersen & Co., Guardion said.

Guardion said it is "a specialty health sciences company that develops clinically supported nutrition, medical foods and medical devices, with a focus in the ocular health marketplace."

[Viewmont]

GRAB SHARES!

[Viewmont]

Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive Officer

SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ("Guardion" or the "Company"), a specialty health sciences company that develops clinically supported nutrition, medical foods and medical devices, with a focus in the ocular health marketplace, today announces the appointment of Bret Scholtes, a veteran of the nutritional products industry for nearly a decade, as its President and Chief Executive Officer, and as a member of the Board of Directors, commencing January 6, 2021.

"We are delighted to welcome Bret to Guardion Health Sciences. We believe that his proven business acumen and extensive experience in the nutritional products industry will serve to usher Guardion into a new era of growth and success," commented Robert Weingarten, Chairman of the Board of Guardion Health Sciences. "Bret's accomplishments as a leader of a NYSE-listed nutritional products company include significant and sustained revenue and profit growth, a successful acquisition and integration strategy, and ultimately a significant liquidity event for its public stockholders. We believe that Bret's experience will provide the tools and leadership skills that Guardion requires to develop and execute both near-term and longer-term business strategies focused on product and market development that will translate into revenue growth and ultimately profitability. We believe that these efforts will ultimately drive stockholder value."

Mr. Weingarten continued, "We have structured Bret's compensation package in a way that aligns his strategic focus with the primary goal of our shareholders, which is to increase stockholder value. The Board also thanks Dr. David Evans for his valuable stewardship while serving as the Company's interim President and Chief Executive Officer during these extraordinary times."

Mr. Scholtes has spent the last 9 years as CEO of Omega Protein Corporation ("Omega"), a global nutritional products company which traded on the New York Stock Exchange until it was successfully sold to a strategic buyer in late 2017. Omega operated branded and private label ingredient businesses with more than 1,100 employees. During his time at Omega, annualized revenues increased by 55%, EBITDA grew by more than 70%, and Omega's stock price increased by approximately 260%. In addition, Mr. Scholtes spearheaded the acquisition of four companies, which added approximately $125 million to revenues through complementary product lines, introduced more than 40 new products, and expanded successfully into several new markets. Prior to his time at Omega, Mr. Scholtes served as Vice President, Origination at GE Energy Financial Services, where he co-originated acquisitions with a combined enterprise value of more than $4 billion. He has also held several corporate development and public accounting positions, including periods at Price Waterhouse and Arthur Andersen & Co. Mr. Scholtes holds a Master of Business Administration degree from New York University, a Bachelor of Science degree in Accounting from the University of Missouri, and is a certified public accountant.

Mr. Scholtes commented, "I was immediately attracted to Guardion Health Sciences for its scientifically-proven nutritional products and medical foods, combined with a product line of evidence-based diagnostic technologies, which together provide an elegant combination of products and technologies that mirror what we have seen in other treatment areas covered by the pharmaceutical and diagnostic spaces. The current market environment presents multiple challenges, from acceptance of the science behind medical foods and nutritional supplements, to distribution issues that emerged from the COVID-19 pandemic, to expanding our markets in Asia and other territories. However, I am confident that my experience can help drive Guardion's successful implementation of its business plans and objectives based on evidence-based protocols, and I look forward to working with Guardion's management team and directors to drive current products into the market and bring unique and compelling new products to the market to support the health and well-being of its customers."